Venus Remedies Limited (NSE:VENUSREM)
1,686.80
-88.70 (-5.00%)
Jul 22, 2026, 3:30 PM IST
Venus Remedies Employees
Venus Remedies had 1,298 employees as of March 31, 2025. The number of employees increased by 111 or 9.35% compared to the previous year.
Employees
1,298
Change (1Y)
111
Growth (1Y)
9.35%
Revenue / Employee
6.25M INR
Profits / Employee
894.84K INR
Market Cap
23.89B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 1,298 | 111 | 9.35% |
| Mar 31, 2024 | 1,187 | 189 | 18.94% |
| Mar 31, 2023 | 998 | 56 | 5.94% |
| Mar 31, 2022 | 942 | 105 | 12.54% |
| Mar 31, 2021 | 837 | -72 | -7.92% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Solara Active Pharma Sciences | 1,775 |
| Sigachi Industries | 1,507 |
| Jagsonpal Pharmaceuticals | 1,399 |
| Windlas Biotech | 1,385 |
| RPG Life Sciences | 1,366 |
| Ind-Swift Laboratories | 1,246 |
| Orchid Pharma | 736 |
Venus Remedies News
- 15 days ago - Venus Remedies announces special window for re-lodgement of physical share transfers - Business Upturn
- 5 weeks ago - Venus Remedies urges shareholders to update KYC details via social media - Business Upturn
- 6 weeks ago - Venus Remedies secures renewal of DSIR in-house R&D recognition - Business Upturn
- 2 months ago - Venus Remedies hits 5% upper circuit at all-time high as FY26 profit more than doubles to ₹102.78 crore - Business Upturn
- 2 months ago - Venus Remedies announces ₹10 per share final dividend with record date set for August 2026 - Business Upturn
- 2 months ago - Venus Remedies schedules AGM for August 2026 and announces dividend - Business Upturn
- 2 months ago - Venus Remedies shares rally 4% after Saudi Arabia approves oncology drug Plerixafor for global marketing authorization - Business Upturn
- 2 months ago - Venus Remedies receives Saudi FDA approval for Plerixafor - Business Upturn